本页面由Tiger Trade Technology Pte. Ltd.提供服务

BioLife Solutions Inc.

37.19
+0.09000.24%
盘后37.190.00000.00%19:30 EDT
成交量:54.85万
成交额:2,034.36万
市值:18.19亿
市盈率:31.97
高:37.37
开:36.81
低:36.40
收:37.10
52周最高:38.10
52周最低:17.86
股本:4,890.00万
流通股本:4,268.01万
量比:0.94
换手率:1.29%
股息:- -
股息率:- -
每股收益(TTM):1.16
每股收益(LYR):-0.0962
净资产收益率:12.83%
总资产收益率:0.26%
市净率:4.33
市盈率(LYR):-386.50

数据加载中...

2026/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/08/04

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2026/08/03

重要事件披露

Form 8-K - Current report
2026/07/24

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2026/07/22

重要事件披露

Form 8-K - Current report
2026/07/22

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2026/06/04

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/03

重要事件披露

Form 8-K - Current report
2026/05/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/07

重要事件披露

Form 8-K - Current report
2026/05/06

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/28

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2026/03/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities